首页 | 本学科首页   官方微博 | 高级检索  
检索        

国产复方非洛地平缓释片治疗原发性高血压的疗效和安全性
引用本文:HUANG Gaozhong,黄高忠,吴宗贵,陈绍行,张昀昀,吴士尧,章建梁.国产复方非洛地平缓释片治疗原发性高血压的疗效和安全性[J].中国临床药学杂志,2008,17(3):148-151.
作者姓名:HUANG Gaozhong  黄高忠  吴宗贵  陈绍行  张昀昀  吴士尧  章建梁
作者单位:1. 上海交通大学附属第六人民医院老年科,上海,200233
2. 中国人民解放军第二军医大学附属长征医院心内科,上海,200003
3. 上海交通大学医学院瑞金医院心内科,上海,200025
4. 上海交通大学医学院第九人民医院心内科,上海,200011
5. 中国人民解放军第二军医大学附属长海医院心内科,上海,200433
摘    要:目的 评价国产复方非洛地平缓释片治疗轻、中度原发性高血压的疗效和安全性.方法 采用多中心、随机、双盲双模拟、前瞻性平行对照方法,从321例高血压患者中筛选出经非洛地平(5mg)单药治疗4wk、血压不能满意控制者217例,随机分为试验组和对照组,继续治疗8wk,分别服用复方非洛地平缓释片(由马来酸依那普利和缓释非洛地平组成,5mg/5mg)1片和非洛地平缓释片(5mg)、马来酸依那普利片(5mg)各1片.双盲治疗4wk后DBP不低于90mm Hg(1mm Hg=0.133kPa)者剂量加倍.结果 前4wk非洛地平单药治疗的有效率32.4%,降压无效而人组者血压平均下降(5.4±3.3/2.7±1.9)mm Hg.后8wk联合用药降压的总有效率试验组和对照组分别为88.3%和92.2%,血压分别进一步下降16.2/10.5mm Hg和14.8/11.4mm Hg.单药的不良反应主要为头痛、头晕、头胀、面部潮红等(12.0%).双盲试验期不良反应总发生率试验组和对照组分别为19.4%和14.7%,其中干咳发生率分别占6.5%和8.3%.结论 国产复方非洛地平缓释片治疗轻、中度原发性高血压安全、有效.

关 键 词:复方制剂  非洛地平  高血压  临床试验  复方非洛地平缓释片  继续治疗  原发性高血压  疗效和安全性  essential  hypertension  patients  tablets  felodipine  compound  safety  干咳  发生率  双盲试验  面部潮红  头痛  不良反应  单药  组分  总有效率  联合用药
文章编号:1007-4406(2008)03-0148-04
修稿时间:2007年6月15日

Efficacy and safety of compound felodipine sustained-release tablets in patients with essential hypertension
HUANG Gaozhong,WU Zonggui,CHEN Shaoxing,ZHANG Yunyun,WU Shiyao,ZHANG Jianliang.Efficacy and safety of compound felodipine sustained-release tablets in patients with essential hypertension[J].Chinese Journal of Clinical Pharmacy,2008,17(3):148-151.
Authors:HUANG Gaozhong  WU Zonggui  CHEN Shaoxing  ZHANG Yunyun  WU Shiyao  ZHANG Jianliang
Institution:HUANG Gaozhong1,WU Zonggui2,CHEN Shaoxing3,ZHANG Yunyun1,WU Shiyao4,ZHANG Jianliang5(1Department of Gerontology,Sixth People\' s Hospital,Shanghai Jiaotong University,Shanghai 200233,China,2 Department of Cardiology,Changzheng Hospital,Second Military Medical University of PLA,Shanghai 200003,3 Department of Cardiology,Ruijin Hospital,School of Medicine,Shanghai 200025,4Department of Cardiology,Ninth People\'s Hospital,...
Abstract:AIM To evaluate the efficacy and safety of compound felodipine sustained-release tablets(domestic product) in patients with mildto-moderate essential hypertension.METHODS This was a double-blind,randomized,controlled multicenter clinical trial.Patients with essential hypertension (n=321) were treated with placebo for 2 wk,then felodipine sustained-release tablets for 4 wk.Those patients whose blood pressure were still not lower than 140/90 mm Hg(1 mm Hg=0.133 kPa) were randomly assigned to receive compound ...
Keywords:compound preparation  felodipine  hypertension  clinical trial  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号